In C4 separation units receiving mixed butane-butene streams from naphtha steam-cracker heaters, extractive distillation of 1,3-butadiene is operated with anhydrous acetonitrile-water mixtures as the selective polar solvent. The solvent is introduced at a tray position above the C4 feed, while the feed enters at a lower plate; the polar solvent increases relative volatility of butanes and butenes over 1,3-butadiene, driving 1,3-butadiene downward with the solvent-rich bottom liquid. In open engineering descriptions of licensed flowsheets, the solvent-to-feed mass ratio is maintained between 4:1 and 7:1, with the recycle solvent water fraction adjusted to 8–15 wt%. The extractive distillation column is typically a structured-packed tower operated at overhead pressures of 3.5–5.0 bar g and bottom temperatures of 120–150 °C; reboiler duty is set by solvent circulation rather than C4 feed rate, and reboiler fouling becomes the dominant production bottleneck when vinylacetylene and polymer precursors accumulate in the solvent loop. Solvent regeneration is conducted below 160–170 °C to limit acetonitrile hydrolysis to acetamide and acetic acid, and the recovered solvent is dehydrated to the specified water fraction before re-injection.

Downstream, the C4 feed is pre-washed with caustic to remove carbonyls, dried, and routed to the extractive distillation column. The overhead raffinate is partially condensed and sent to downstream selective hydrogenation or MTBE etherification units. The solvent-rich bottom stream is depressured into a stripper where crude 1,3-butadiene is released; the crude is then distilled in two further columns to remove methylacetylene and heavy C5+ components. Terminal products are polymer-grade 1,3-butadiene with purity ≥99.5 wt%, butane-butene raffinate, 1-butene-rich raffinate fractions, and regenerated acetonitrile. Product butadiene is stabilized with 50–150 ppm 4-tert-butylcatechol for storage and transport. Compliance is controlled through OSHA 29 CFR 1910.119 process safety management, EU 2012/18/EU major-accident prevention, ASME B31.3 piping design, and ISO 9001:2015 quality management. Published numeric data for specific column internal configurations remains limited because licensors restrict proprietary hydraulic and tray-efficiency datasets.

What Changes in Sequence Fidelity Occur When DNA-Synthesis-Grade Acetonitrile Water Content Rises Above 30 ppm?

Acetonitrile used in solid-phase phosphoramidite oligonucleotide assembly functions both as the primary wash solvent and as the diluent for 0.05–0.10 M phosphoramidite monomer solutions and 0.25 M 5-ethylthio-1H-tetrazole activator. Water content in fresh solvent is controlled to ≤30 ppm by Karl Fischer titration per ASTM E1064-16, because residual water competes with phosphoramidite activation and reduces stepwise coupling yield. On automated synthesizers with controlled pore glass or polystyrene supports, the cycle comprises detritylation with trichloroacetic acid in dichloromethane, acetonitrile wash volumes of 10–15 column volumes, monomer coupling, capping with acetic anhydride/lutidine, and iodine/pyridine/water oxidation. Column scales range from 1 µmol to 10 mmol; at the upper scale, acetonitrile consumption per synthesis can exceed 0.5 L. Compliance for the resulting oligonucleotide API or reagent follows ICH Q3C Class 2 residual solvent criteria, with acetonitrile PDE 4.1 mg/day and drug-product limit 410 ppm; release testing uses USP <467> headspace gas chromatography. Terminal products include therapeutic antisense oligonucleotides, siRNA duplexes, aptamers, PCR primers, and sequencing library adapters.

Production-scale failure modes: insufficient acetonitrile drying causes coupling efficiencies to drop below 98.5%, increasing n–1 deletion impurities that are difficult to resolve from full-length product by anion-exchange HPLC. Batch-to-batch variation in acetonitrile UV absorbance at 254 nm must remain below 0.05 AU; higher values indicate distillation residues or stabilizer carry-over that interfere with downstream purification. Final cleavage and deprotection typically uses 28–30% ammonium hydroxide at 55 °C for 8–15 h; acetonitrile does not participate in cleavage but must be quantitatively removed before lyophilization to meet the 410 ppm residual solvent criterion.

Transferring a compendial reversed-phase impurity method between QC laboratories requires control of acetonitrile grade, pH, and column temperature because the organic modifier selectively elutes hydrophobic degradants without buffering capacity. In routine pharmaceutical release testing, acetonitrile is blended with aqueous buffers at 5–95 vol%; for low-pH separations, 0.1% trifluoroacetic acid or 10 mM phosphate buffer is used, while high-pH methods employ 10 mM ammonium bicarbonate with mass spectrometry detection. The chromatographic system is configured with a 2.1 × 100 mm, 1.7 µm C18 column, a flow rate of 0.25–0.40 mL/min, and a column temperature of 30–40 °C per USP <621> allowable adjustments. Suitability limits for tailing factor and resolution follow ICH Q2(R1); instrument qualification follows ISO/IEC 17025:2017. The downstream process includes sample dissolution in 50:50 acetonitrile-water, filtration through 0.22 µm PVDF syringe filters, gradient elution, and UV detection at 210–280 nm or tandem quadrupole mass spectrometry. Terminal outputs are certificates of analysis, stability trend data, and forced-degradation impurity profiles for API release. Acetonitrile must be HPLC gradient grade with low particulate content and UV transmittance above 95% at 210 nm; published supplier specifications vary, so each method transfer includes mobile-phase pre-testing against the reference chromatogram.

When Tetraethylammonium Tetrafluoroborate Is Dissolved in Acetonitrile for Electric Double-Layer Capacitors, Rated Voltage Is Governed by Electrolyte Water Content and Carbon Electrode Impurities

Electrolytes for electric double-layer capacitors are formulated from 1.0–1.5 M quaternary ammonium tetrafluoroborate salts in high-purity acetonitrile; the most common is triethylmethylammonium tetrafluoroborate, with room-temperature conductivity near 55–60 mS/cm. The electrolyte is not tolerant of moisture: water content must be held below 20 ppm, and oxygen must be excluded during filling because trace water electrolysis and acetonitrile electro-oxidation produce HF and CO₂, leading to cell swelling and equivalent series resistance rise. Filling operations are performed in dry rooms with dew point at or below −40 °C; cells are vacuum-filled and aged at 2.7 V rated voltage. Acetonitrile purity is typically 99.99%, with propionitrile and allyl alcohol impurities controlled because they adsorb on activated carbon electrodes and shift leakage current. Compliance includes cell safety and performance testing per IEC 62391-1:2015 and IEC 62391-2:2015, material restrictions per RoHS 2011/65/EU, and electrolyte documentation under REACH (EC) No 1907/2006. Terminal products are EDLC cells for smart-meter real-time clocks, industrial memory backup, wind-turbine pitch-control modules, automotive start-stop modules, and LED emergency lighting.

Production-scale failure modes include separator wetting gradients when electrolyte fill rate exceeds the wetting capacity of the activated carbon electrode in 18650 cylindrical cells and pouch-cell stacks, resulting in capacitance imbalance across electrode windings. Vacuum infiltration is followed by a 12–24 h aging step at 60 °C with voltage hold; cells exceeding gas-generation thresholds are rejected by end-of-line ESR testing. Published data for calendar-life projections at 3.0 V is limited; above 3.0 V, acetonitrile oxidation currents increase and consume electrolyte, so operational voltage is deliberately derated to 2.5–2.7 V for multi-year service life.

In multiresidue pesticide monitoring, acetonitrile serves as the extraction solvent and phase-separation driver in the EN QuEChERS workflow because its aprotic polarity gives high recovery for a broad polarity range without co-extracting excessive lipid from high-fat matrices. The standard extraction ratio is 10 mL acetonitrile per 10 g homogenized sample, followed by partitioning salts: 4 g anhydrous magnesium sulfate, 1 g sodium chloride, 1 g trisodium citrate dihydrate, and 0.5 g disodium hydrogen citrate sesquihydrate per EN 15662:2018. After shaking and centrifugation, an aliquot is cleaned by dispersive solid-phase extraction with 150 mg primary secondary amine and 900 mg magnesium sulfate per 1 mL extract for chlorinated and organophosphorus residues. The process equipment includes high-speed homogenizers or pulsed vortexers and refrigerated centrifuges at 3000–5000 × g. Acetonitrile used for LC-MS/MS multiresidue methods must be of low ion-suppression grade, with ammonium formate or formic acid added at 5 mM or 0.1% in the final injection solution. Compliance includes EN 15662:2018, AOAC Official Method 2007.01, and ISO/IEC 17025:2017 for accredited laboratory reporting. Terminal products are regulatory MRL compliance reports, import/export residue certificates, and accredited data packages for high-risk produce, cereals, and processed infant food. Published supplier specifications for pesticide-grade acetonitrile vary, so each lot is batch-tested for non-volatile residue and LC-MS ion suppression before use.

Preparative RP-HPLC Fractions and Class 2 Residual Solvent Control for Peptide APIs

Large-scale reversed-phase purification of synthetic peptide active pharmaceutical ingredients relies on acetonitrile-water gradients because acetonitrile provides sufficient resolving power for deletion and oxidation variants while remaining removable by rotary evaporation and lyophilization. Preparative methods typically run gradient spans of 10–45 vol% acetonitrile in water with 0.1% trifluoroacetic acid or 1% acetic acid over 30–60 min, using dynamic axial compression columns of 20–60 cm internal diameter packed with 10–15 µm C18 or C8 silica. Crude peptide loadings of 1–5 g/L column volume are common for high-purity fractions, with UV detection at 220 nm and fraction collection triggered by threshold absorbance. Compliance for the resulting peptide API follows ICH Q7 GMP, ICH Q3C Class 2 residual solvent criteria with acetonitrile PDE 4.1 mg/day and limit 410 ppm in drug product, and USP <467> for headspace GC determination. Final solvent removal uses rotary evaporation at 35–40 °C under vacuum, followed by lyophilization; residual acetonitrile in the lyophilized powder is controlled to below 410 ppm, and moisture content is controlled to ≤5% by Karl Fischer titration. Terminal products include lyophilized peptide APIs such as insulin analogues and glucagon-like peptide-1 receptor agonist intermediates, sterile injectable formulations, and reference standards.

Production-scale failure modes include evaporator solvent overload when fraction pools exceed the manufacturer’s heat-transfer limit, leading to incomplete solvent stripping and batch rejection for residual acetonitrile above the Pharmacopoeial limit. Collected fractions containing high trifluoroacetic acid or salt content are diverted to re-purification to prevent glass transition collapse during lyophilization. Published data for specific preparative loading and recovery correlations is limited on a molecule-by-molecule basis; each peptide purification campaign therefore includes a preparative method qualification run before full-scale fractionation.